0QLQ fundamentals
An in-depth look to YPSOMED HOLDING AG CHF14.15 (REGD) operating, investing, and financing activities
0QLQ free cash flow for H2 24 is -25.76 M CHF. For 2024, 0QLQ free cash flow was -57.4 M CHF and operating cash flow was 148.2 M CHF.
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: CHF
TTM